Nordic Bifurcation Study. How to Use Drug Eluting Stents (DES) in Bifurcation Lesions?
BIFI
1 other identifier
interventional
413
1 country
1
Brief Summary
How to use drug eluting stents (DES) in bifurcation lesions. A strategy of routine stenting of both main vessel and side branch versus a strategy of routine main vessel stenting and optional treatment of side branch. A randomized Nordic multicenter study including 400 patients with angina pectoris with clinical angiographic follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4 coronary-artery-disease
Started Oct 2004
Longer than P75 for phase_4 coronary-artery-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2004
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2005
CompletedFirst Submitted
Initial submission to the registry
September 14, 2006
CompletedFirst Posted
Study publicly available on registry
September 15, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2011
CompletedJanuary 2, 2026
December 1, 2025
8 months
September 14, 2006
December 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Combined end-point of cardiac death, MI, stent thrombosis or TVR.
After 6 months
Secondary Outcomes (2)
Clinical: MACE (cardiac death, MI, stent thrombosis or TVR) during hospital period, after 1 and 8 months. Cardiac death, myocardial infarction, stent thrombosis, TVR, total death, TLR during hospital period, after 1, 6 and 8 months. Myocardial infarction
During hospital period, after 1, 6 and months.
Angiographic: Restenosis of the main vessel and/or occlusion of the side branch. Late loss of main vessel and side branch after 8 months. Angiographic restenosis (>50% diameter stenosis) rate of main vessel and side branch after 8 months.
After 8 months
Study Arms (2)
Stenting of main vessel and side branch
EXPERIMENTALPercutaneous coronary intervention
No side branch treatment
EXPERIMENTALPercutaneous coronary intervention
Interventions
Comparing treatment of either "no side branch treatment" versus "stenting of main vessel and side branch treatment"
Eligibility Criteria
You may qualify if:
- Stable or unstable AP.
- Bifurcation lesion of "LAD/diagonal", "Cx/obtuse marginal", "RCA-PDA/posterolateral branch or LM/Cx/LAD in a right dominant system.
- Diameter of main vessel by visual estimate \> 2.5 mm.
- Diameter of side branch by visual estimate \> 2.0 mm.
- Signed informed consent.
You may not qualify if:
- ST-elevation AMI within 24 hours.
- Expected survival \< 1 year.
- S-creatinine \> 200 Umol/l.
- Allergy to Aspirin, Clopidogrel or Ticlopidine.
- Allergy to sirolimus/paclitaxel.
- Left main bifurcation in a non-right dominant system.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aarhus University Hospital Skejbylead
- Johnson & Johnsoncollaborator
Study Sites (1)
Skejby Hospital, University of Aarhus
Aarhus, 8200, Denmark
Related Publications (3)
Behan MW, Holm NR, de Belder AJ, Cockburn J, Erglis A, Curzen NP, Niemela M, Oldroyd KG, Kervinen K, Kumsars I, Gunnes P, Stables RH, Maeng M, Ravkilde J, Jensen JS, Christiansen EH, Cooter N, Steigen TK, Vikman S, Thuesen L, Lassen JF, Hildick-Smith D. Coronary bifurcation lesions treated with simple or complex stenting: 5-year survival from patient-level pooled analysis of the Nordic Bifurcation Study and the British Bifurcation Coronary Study. Eur Heart J. 2016 Jun 21;37(24):1923-8. doi: 10.1093/eurheartj/ehw170. Epub 2016 May 8.
PMID: 27161619DERIVEDKervinen K, Niemela M, Romppanen H, Erglis A, Kumsars I, Maeng M, Holm NR, Lassen JF, Gunnes P, Stavnes S, Jensen JS, Galloe A, Narbute I, Sondore D, Christiansen EH, Ravkilde J, Steigen TK, Mannsverk J, Thayssen P, Hansen KN, Helqvist S, Vikman S, Wiseth R, Aaroe J, Jokelainen J, Thuesen L; Nordic PCI Study Group. Clinical outcome after crush versus culotte stenting of coronary artery bifurcation lesions: the Nordic Stent Technique Study 36-month follow-up results. JACC Cardiovasc Interv. 2013 Nov;6(11):1160-5. doi: 10.1016/j.jcin.2013.06.009.
PMID: 24262616DERIVEDBehan MW, Holm NR, Curzen NP, Erglis A, Stables RH, de Belder AJ, Niemela M, Cooter N, Chew DP, Steigen TK, Oldroyd KG, Jensen JS, Lassen JF, Thuesen L, Hildick-Smith D. Simple or complex stenting for bifurcation coronary lesions: a patient-level pooled-analysis of the Nordic Bifurcation Study and the British Bifurcation Coronary Study. Circ Cardiovasc Interv. 2011 Feb 1;4(1):57-64. doi: 10.1161/CIRCINTERVENTIONS.110.958512. Epub 2011 Jan 4.
PMID: 21205942DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Leif Thuesen, MD
Director, Cardiac Cath. Lab., Skejby Hospital, University of Aarhus
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
September 14, 2006
First Posted
September 15, 2006
Study Start
October 1, 2004
Primary Completion
June 1, 2005
Study Completion
March 1, 2011
Last Updated
January 2, 2026
Record last verified: 2025-12